Gilead Sciences, Inc.
NASDAQ:GILDDrug Manufacturers - General
Healthcare
$168.98 -2.14%
-$2.69 today
- Market cap
- $209.59B
- Beta
- 0.33
- P/E (TTM)
- 16.5
- EPS (TTM)
- $7.42
- Dividend yield
- 2.62%
52W Low $104.46High $157.29
Volume 4.82M
Average 6.78M
News
For Gilead Sciences, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for GILD yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research
- Gilead Sciences, Inc. (GILD) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha
- Gilead Sciences, Inc. (GILD) Presents at UBS Global Biopharma Conference 2026 Transcript
Seeking Alpha
- Gilead Sciences Maps Growth Beyond BIKTARVY With HIV, Cancer and Inflammation Drugs
MarketBeat
- Suffolk Celebrates Completion of Gilead Sciences Research Center With Ribbon Cutting
Business Wire
- Gilead Sciences Bets on HIV Prevention Growth Despite $1.5 Billion Biktarvy Headwind
MarketBeat
- Gilead Expands Access to Investigational Obeldesivir for Ebola Bundibugyo Virus Disease Through Voluntary Licensing
Business Wire
Continue the stock analysis
Jump to another research area for this company.